Sequencing Consumables Global Market Report 2024

The sequencing consumables market size has grown exponentially in recent years. It will grow from $7.74 billion in 2023 to $9.79 billion in 2024 at a compound annual growth rate (CAGR) of 26.5%. The growth in the historic period can be attributed to increased prevalence of genetic disorders and target diseases, increased number of drug development activities, increased use of miniaturized portable instruments, high use of biomarker profiling, high demand for personalized medicine, and the increased number of cancer patients.

The sequencing consumables market size is expected to see exponential growth in the next few years. It will grow to $25.34 billion in 2028 at a compound annual growth rate (CAGR) of 26.8%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include advanced disease detection and monitoring, innovations in drug discovery, advancement in target validation, biomarker identification, advanced DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

The anticipated increase in the prevalence of genetic diseases is poised to drive the expansion of the sequencing consumables market in the foreseeable future. Genetic diseases denote disorders arising from abnormalities in an individual's DNA or genes, often inherited from their parents. This upward trend in genetic disease prevalence is credited to factors such as heightened awareness, enhanced diagnostics, and evolving environmental conditions. Sequencing consumables play a pivotal role in genetic disease management, facilitating DNA extraction, library preparation, sequencing, and analysis to pinpoint genetic variants linked to diseases. For instance, as of April 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that approximately 6,000 babies are born with Down syndrome in the United States annually, occurring at a rate of about 1 in every 700 births. Hence, the escalating prevalence of genetic diseases acts as a catalyst for the expansion of the sequencing consumables market.

Leading companies in the sequencing consumables market are concentrating on the development of innovative solutions, such as human whole-genome sequencing (WGS) assays, to improve accuracy, efficiency, and speed in genomic analysis. Human whole-genome sequencing (WGS) assays entail a thorough examination of an individual's complete genome, encompassing all DNA, to detect genetic variations, mutations, and biomarkers linked to health, disease susceptibility, and response to treatment. For instance, in March 2023, Illumina Inc., a US-based biotechnology firm, introduced Illumina Complete Long Read Prep- Human, a high-performance, long-read, human whole-genome sequencing (WGS) assay. The Illumina Complete Long Read Prep, Human is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. It grants users access to both long- and short-read data on a single Illumina instrument for the first time. This offering streamlines workflows and substantially decreases DNA input requirements compared to other long-read alternatives.

In March 2021, Integrated DNA Technologies (IDT), a US-based provider of genomic solutions, acquired Swift Biosciences for an undisclosed sum. This acquisition enables IDT to bolster its current NGS product portfolio and deliver comprehensive solutions to researchers spanning diverse domains including cancer research, inherited diseases, agrigenomics, metagenomics, and the biotech or pharmaceutical sector. Swift Biosciences, also based in the US, specializes in offering genomics kits for library preparation, including DNA sequencing kits and DNA preparation kits, catering to academic, translational, and clinical research purposes.

Major companies operating in the sequencing consumables market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Becton, Dickinson and Company, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Group AG, BGI Genomics Co Ltd, Promega Corporation, Abcam Limited, Integrated DNA Technologies Inc., Takara Bio Inc, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, Analytik Jena GmbH, Standard BioTools Inc, LGC Biosearch Technologies Inc., Biocartis SA, Apex Biotechnology Corp., Lexogen GmbH.

North America was the largest region in the sequencing consumables market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sequencing consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sequencing consumables encompass the reagents, kits, and materials utilized during DNA or RNA sequencing. These essential items are used for preparing, amplifying, and analyzing genetic samples within sequencing workflows. Designed to be compatible with specific sequencing platforms and technologies, sequencing consumables ensure the accuracy, efficiency, and reliability of genomic data generation.

The primary components of sequencing consumables include kits, reagents, and accessories. Sequencing kits are laboratory resources comprising essential reagents and protocols for DNA or RNA sequencing procedures. These consumables span across first-generation, second-generation, and third-generation sequencing platforms, serving various applications such as cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics, pharmacogenomics, agrigenomics, among others. End-users, including pharmaceutical and biotechnology firms, hospitals, laboratories, academic research institutions, and others, utilize these consumables.

The sequencing consumables research report is one of a series of new reports that provides sequencing consumables market statistics, including the sequencing consumables industry's global market size, regional shares, competitors with a sequencing consumables market share, detailed sequencing consumables market segments, market trends and opportunities, and any further data you may need to thrive in the sequencing consumables industry. This sequencing consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sequencing consumables market consists of sales of enzymes, reagents, kits, buffers, and plates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.